Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition.1 Due to its longer duration of action, it is typically administered subcutaneously once weekly. The safety profile of semaglutide is similar to …
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition.1 Due to its longer duration of action, it is typically administered subcutaneously once weekly. The safety profile of semaglutide is similar to … Continue reading "Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports"
Dermatologic procedures in children can be stressful for the patient, parent and the clinician. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Watch as Dr. Kirkorian shares four hot tips for procedures in kids. Find out why you might want to reconsider some … 
TikTok is a source of beauty and skin health information for the masses. Yet much of the content is not produced by board-certified dermatologists or even other healthcare professionals. So who’s creating TikTok content about sun protection and skin cancer? Does any of this content address skin of color? Those are the questions a new cross-sectional analysis published in the July Journal of Drug … 
Alopecia areata (AA) is a nonscarring alopecia driven by autoreactive cytotoxic CD8 T cells against hair follicle antigens. With an unpredictable clinical course, which can include alopecia totalis and universalis, AA can be debilitating to patients’ quality of life. Historically, glucocorticosteroids, cyclosporine, methotrexate, and azathioprine were used off-label for non-targeted immunosuppre … 
In the August edition of the Journal of Drugs in Dermatology (JDD), we turn our focus to psoriasis, one of the most challenging and impactful dermatological conditions. This month’s Editor's Picks showcase a series of in-depth studies and expert discussions that explore the latest advancements in psoriasis treatment, real-world effectiveness, and the broader implications of the disease … 